Primary CNS lymphoma - A whole-brain disease?

被引:123
作者
Lai, R
Rosenblum, MK
DeAngelis, LM
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
关键词
D O I
10.1212/01.WNL.0000034256.20173.EA
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Autopsy studies reveal that most primary CNS lymphomas (PCNSL) extensively infiltrate the brain. To date, there has been no correlation of autopsy findings with a modern neuroimaging assessment of tumor burden. Objective: To correlate autopsy findings in PCNSL to MRI findings. Method: From the authors' database of immunocompetent patients with PCNSL diagnosed between 1985 and 2001, 10 patients who died and had PCNSL at autopsy were identified. Their pathology was compared to MR scans obtained shortly before death. Results: The median patient age was 60 years (range 44 to 80 years). There were six men and four women. Scans were performed within 4 weeks of death in seven patients, within 3 months in two patients, and within 4 months in one. Seven had enhancing lesions consistent with recurrence, and two of the three had focal T2 abnormalities. All had periventricular white matter abnormalities on T2 MR images. At autopsy, all 10 patients had widespread lymphoma throughout the CNS, but no tumor was found systemically. All had tumor infiltration in CNS regions that were normal radiographically, including T2 sequences. Conclusions: MRI underestimates the tumor,burden of PCNSL. Bulky disease is seen as a contrast-enhancing lesion because of disruption of the blood-brain barrier, but microscopic tumor infiltration may lead to T2 hyperintensity or be completely normal radiographically.
引用
收藏
页码:1557 / 1562
页数:6
相关论文
共 15 条
[1]  
Abrey Lauren E., 1997, Neurology, V48, pA18
[2]   Treatment for primary CNS lymphoma: The next step [J].
Abrey, LE ;
Yahalom, J ;
DeAngelis, LM .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3144-3150
[3]   Lymphomatosis cerebri presenting as a rapidly progressive dementia: Clinical, neuroimaging and pathologic findings [J].
Bakshi, R ;
Mazziotta, JC ;
Mischel, PS ;
Jahan, R ;
Seligson, DB ;
Vinters, HV .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (02) :152-157
[4]   MANAGEMENT OF PRIMARY CEREBRAL LYMPHOMA WITH INITIAL CHEMOTHERAPY - PRELIMINARY-RESULTS AND COMPARISON WITH PATIENTS TREATED WITH RADIOTHERAPY ALONE [J].
BRADA, M ;
DEARNALEY, D ;
HORWICH, A ;
BLOOM, HJG .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 18 (04) :787-792
[5]   MRI features of primary central nervous system lymphomas at presentation [J].
Bühring, U ;
Herrlinger, U ;
Krings, T ;
Thiex, R ;
Weller, M ;
Küker, W .
NEUROLOGY, 2001, 57 (03) :393-396
[6]   CEREBRAL LYMPHOMA PRESENTING AS A NONENHANCING LESION ON COMPUTED TOMOGRAPHIC MAGNETIC-RESONANCE SCAN [J].
DEANGELIS, LM .
ANNALS OF NEUROLOGY, 1993, 33 (03) :308-311
[7]   Primary central nervous system lymphoma [J].
DeAngelis, LM .
CURRENT OPINION IN NEUROLOGY, 1999, 12 (06) :687-691
[8]   Primary CNS lymphoma: Treatment with combined chemotherapy and radiotherapy [J].
DeAngelis, LM .
JOURNAL OF NEURO-ONCOLOGY, 1999, 43 (03) :249-257
[9]  
Johnson BA, 1997, AM J NEURORADIOL, V18, P563
[10]  
NAKHLEH RE, 1989, ARCH PATHOL LAB MED, V113, P1050